Pharma Reviews: Indian pharma companies better off than global peers: Moody's

According to Moody's, Indian pharma market is highly fragmented with the largest player accounting for 8.8% of the $12 to $15 billion market.
Read more: Indian pharma companies better off than global peers: Moody's